Drug details

Lutrate Depot (leuprolide acetate for depot suspension)

type of Antineoplastics, GNRH Agonists

Lutrate Depot (leuprolide acetate for depot suspension) is a gonadotropin-releasing hormone (GnRH) agonist indicated for palliative treatment of advanced prostatic cancer.

This drug may have the following side effects:

• nausea,
• diarrhea,
• dizziness,
• constipation,
• joint pain,
• back pain,
• headache,
• itching
• flushing,
• urinary tract infection (UTI),
• pain in extremities,
• frequent urination,
• bone pain,
• upper respiratory infection,
• fatigue/weakness,
• injection site pain or discomfort,
• nighttime urination,
• abdominal pain/discomfort,
• urinary tract pain,
• high blood pressure (hypertension), and

The following drugs are related to Lutrate Depot, either as a replacement or used together:

• Zytiga (abiraterone acetate tablets)
• Casodex (bicalutamide)
• Jevtana (cabazitaxel injection)
• Firmagon (degarelix for injection)
• Taxotere (docetaxel for injection)
• Eligard (leuprolide acetate)
• Xtandi (enzalutamide capsules)
• Zoladex 10.8 mg (goserelin acetate implant)
• Zoladex 3.6 (goserelin acetate implant)
• Lupron Depot (leuprolide acetate for depot suspension)
• Lupron (leuprolide acetate injection)
• Provenge (sipuleucel-t suspension for intravenous infusion)
• Xofigo (radium ra 223 dichloride)